207 related articles for article (PubMed ID: 11980636)
1. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.
Mabjeesh NJ; Post DE; Willard MT; Kaur B; Van Meir EG; Simons JW; Zhong H
Cancer Res; 2002 May; 62(9):2478-82. PubMed ID: 11980636
[TBL] [Abstract][Full Text] [Related]
2. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
Schwock J; Geddie WR; Hedley DW
Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
[TBL] [Abstract][Full Text] [Related]
4. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
[TBL] [Abstract][Full Text] [Related]
5. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
[TBL] [Abstract][Full Text] [Related]
6. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion.
Zagzag D; Nomura M; Friedlander DR; Blanco CY; Gagner JP; Nomura N; Newcomb EW
J Cell Physiol; 2003 Aug; 196(2):394-402. PubMed ID: 12811834
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG
Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH
Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells.
Zhong H; Hanrahan C; van der Poel H; Simons JW
Biochem Biophys Res Commun; 2001 Jun; 284(2):352-6. PubMed ID: 11394885
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway.
Isaacs JS; Jung YJ; Neckers L
J Biol Chem; 2004 Apr; 279(16):16128-35. PubMed ID: 14764593
[TBL] [Abstract][Full Text] [Related]
11. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
12. Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.
Suzuki H; Tomida A; Tsuruo T
Oncogene; 2001 Sep; 20(41):5779-88. PubMed ID: 11593383
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
16. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin.
Ma Y; Lakshmikanthan V; Lewis RW; Kumar MV
Mol Cancer Ther; 2006 Jan; 5(1):170-8. PubMed ID: 16432176
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
[TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle.
Milkiewicz M; Doyle JL; Fudalewski T; Ispanovic E; Aghasi M; Haas TL
J Physiol; 2007 Sep; 583(Pt 2):753-66. PubMed ID: 17627993
[TBL] [Abstract][Full Text] [Related]
20. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
